Is There a Difference in Patency Between Patients Undergoing Venous Stenting for Acute Deep Venous Thrombosis Following Thrombus Removal Versus Post-thrombotic Syndrome Stenoses?

Venous stenting was introduced in the 1990s and has continued to evolve become first-line therapy for symptomatic iliofemoral venous outflow pathology. There are several dedicated stents available addition Boston Scientific’s Wallstent Cook’s Z-Stent. Numerous studies from tertiary referral centres, as well industry-sponsored trials, have demonstrated safety efficacy of these endovascular devices non-thrombotic iliac vein (NIVL) post-thrombotic syndrome (PTS) lesions. Patients presenting with acute deep thrombosis (aDVT) may also undergo following thrombus removal. The standard care NIVL, PTS aDVT patients venography intravascular ultrasound, if an underlying stenosis is identified, a stent placed. concern that inflammation affect results population. Although diseases appears promising safe, there paucity data on patients. only two trials few publications presentations at academic society meetings examine. This review assesses patients, but not NIVL.